Ono Pharmaceutical , Ltd. Profit Margin

As of the most recent data (September 2026), OPHLY shows a profit margin of 15.17%. That compares with 9.67% in the prior-year period — up 56.8% year over year. That is above the sector sector average of 13.23%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OPHLY's profit margin is now 15.17% (was 9.67%) — a 56.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Ono Pharmaceutical , Ltd. is outperforming or lagging.

The its sector sector average profit margin is about 13.23%. Ono Pharmaceutical , Ltd. is at 15.17%, which is higher that average. That is roughly 14.7% above the sector mean. Use the comparison chart on this page to see how OPHLY stacks up against individual peers as well.

That compares with 9.67% in the prior-year period — up 56.8% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Ono Pharmaceutical , Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Ono Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 15.17%) with ownership activity and broader fundamentals.